GRUPO CANELA PVT LTD
⚠️ High Risk
FEI: 3010259172 • Homagama, Colombo • SRI LANKA
FEI Number
3010259172
Location
Homagama, Colombo
Country
SRI LANKAAddress
282, Katuwana, , Homagama, Colombo, Sri Lanka
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
FILTHY
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the article appears to consist in whole or in part of a filthy, putrid, or decomposed substance or be otherwise unfit for food.
LACKS FIRM
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 3/16/2015 | 28AGB13CINNAMON, CASSIA, WHOLE (SPICE) | 320LACKS FIRM | Division of Southwest Imports (DSWI) |
| 6/20/2014 | 28AHT13CINNAMON, CASSIA, WHOLE (SPICE) | 249FILTHY | Atlanta District Office (ATL-DO) |
| 6/20/2014 | 28AHT13CINNAMON, CASSIA, WHOLE (SPICE) | 249FILTHY | Atlanta District Office (ATL-DO) |
| 2/12/2014 | 28AFH13CINNAMON, CASSIA, WHOLE (SPICE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 2/12/2014 | 28AFH13CINNAMON, CASSIA, WHOLE (SPICE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 2/12/2014 | 28AFH13CINNAMON, CASSIA, WHOLE (SPICE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 1/29/2014 | 28AFH13CINNAMON, CASSIA, WHOLE (SPICE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 1/23/2014 | 28AFH13CINNAMON, CASSIA, WHOLE (SPICE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 1/15/2014 | 28AFH13CINNAMON, CASSIA, WHOLE (SPICE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 1/15/2014 | 28AFH13CINNAMON, CASSIA, WHOLE (SPICE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 12/27/2013 | 28AFH13CINNAMON, CASSIA, WHOLE (SPICE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 10/23/2013 | 28AAT13CINNAMON, CASSIA, WHOLE (SPICE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 10/23/2013 | 28AAT13CINNAMON, CASSIA, WHOLE (SPICE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 10/23/2013 | 28AFT13CINNAMON, CASSIA, WHOLE (SPICE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 10/23/2013 | 28AFT13CINNAMON, CASSIA, WHOLE (SPICE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
| 6/27/2013 | 28AFH13CINNAMON, CASSIA, WHOLE (SPICE) | 249FILTHY | Los Angeles District Office (LOS-DO) |
Frequently Asked Questions
What is GRUPO CANELA PVT LTD's FDA import refusal history?
GRUPO CANELA PVT LTD (FEI: 3010259172) has 16 FDA import refusal record(s) in our database, spanning from 6/27/2013 to 3/16/2015.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. GRUPO CANELA PVT LTD's FEI number is 3010259172.
What types of violations has GRUPO CANELA PVT LTD received?
GRUPO CANELA PVT LTD has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about GRUPO CANELA PVT LTD come from?
All FDA import refusal data for GRUPO CANELA PVT LTD is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.